Sign In

A subscription to JoVE is required to view this content. Sign in or start your free trial.

In This Article

  • Summary
  • Abstract
  • Introduction
  • Protocol
  • Representative Results
  • Discussion
  • Acknowledgements
  • Materials
  • References
  • Reprints and Permissions

Summary

We present a microfluidic cancer-on-chip model, the "Evolution Accelerator" technology, which provides a controllable platform for long-term real-time quantitative studies of cancer dynamics within well-defined environmental conditions at the single-cell level. This technology is expected to work as an in vitro model for fundamental research or pre-clinical drug development.

Abstract

Conventional cell culture remains the most frequently used preclinical model, despite its proven limited ability to predict clinical results in cancer. Microfluidic cancer-on-chip models have been proposed to bridge the gap between the oversimplified conventional 2D cultures and more complicated animal models, which have limited ability to produce reliable and reproducible quantitative results. Here, we present a microfluidic cancer-on-chip model that reproduces key components of a complex tumor microenvironment in a comprehensive manner, yet is simple enough to provide robust quantitative descriptions of cancer dynamics. This microfluidic cancer-on-chip model, the "Evolution Accelerator," breaks down a large population of cancer cells into an interconnected array of tumor microenvironments while generating a heterogeneous chemotherapeutic stress landscape. The progression and the evolutionary dynamics of cancer in response to drug gradient can be monitored for weeks in real time, and numerous downstream experiments can be performed complementary to the time-lapse images taken through the course of the experiments.

Introduction

Cancer has been increasingly recognized as a complex ecosystem that depends not only on the continued dysregulation of mutated cell populations but also on vital interactions between cancer cells and the host microenvironment. In this sense, cancer evolves on an adaptive landscape manifested by a combination of factors, including a heterogeneous tumor microenvironment and crosstalk with a variety of host cells, all of which contribute selective pressures for further genetic or epigenetic changes1,2,3. In the context of solid tumors, uneven distribution of chemotherapeutics an....

Protocol

1. Fabrication of microfluidic device

  1. Generate the desired microfluidic pattern using a layout design software (see Supplemental Materials).
  2. Fabricate the photomask. See Table of Materials for more details.
    1. Utilizing a laser writer, write the pattern on a soda-lime glass plate coated with 100 nm of Cr and 500 nm of photoresist AZ1518.
    2. Develop the photoresist with developer AZ300MIF for 60 s.
    3. Etch away the chromium without protection.......

Representative Results

Validation of optimum cell growth on chip
A major goal of the experiment platform is to reproduce key components and interactions in a complex tumor microenvironment in a comprehensive manner, yet simple enough to provide quantitative, reliable and reproducible data. This goal can only be achieved if we have full control of the physical and biochemical environmental factors. We must either exclude the undesired factors or figure out a way to incorporate the uncontro.......

Discussion

Conventional cell culture was developed almost a century ago and remains the most frequently used preclinical model in biomedical research, despite its proven limited ability to predict clinical results in cancer17. Animal models offer the highest physiological relevance and reasonable genetic similarity to humans, but have long been acknowledged to have significant limitations in predicting human outcomes18. Among all the existing preclinical models, microfluidic cancer-on.......

Acknowledgements

This work was supported by NSF PHY-1659940.

....

Materials

NameCompanyCatalog NumberComments
10 mL BD Luer-Lok tip syringesBD14-823-16E
Antibiotic-AntimycoticSigma-AldrichA59551x anti-anti
AZ 300 MIFMerck KGaA18441123163Photoresist developer
AZ1518Merck KGaAAZ1518Photoresist
AZ4330Merck KGaAAZ4330Photoresist
Cr Chromium EtchantSigma-Aldrich651826
Fetal bovine serum (FBS)Life Technologies Corporation10437028
Heidelberg DWL 66+ laserwriterHeidelberg InstrumentsDWL66+Writing photomask
Hexamethyldisilazane (HMDS)Sigma-Aldrich379212For photoresist adhesion enhancement
Hollow steel pinsNew England Small TubeNE-1300-01 .025 OD .017 ID x .500 long / type 304 WD fullhard
ibidi Heating System, Multi-Well Plates, K-Frameibidi10929On-stage incubator 
Luer-Lok 23 G dispensing needleMcMaster-Carr75165A684To connect syringes and tubings
Lumox dish 35Sarstedt94.6077.331Gas-permeable cell culture dish
Microposit Remover 1165Dow Electronic MaterialsMicroposit Remover 1165Photoresist stripper
Microseal B Adhesive SealerBio-Rad LaboratoriesMSB1001Adhesive sealer
O-Ring (for Lumox plate sealing)McMaster-Carr9452K114Dash No. 27; 1-5/16" ID x 1-7/16" OD; Duro 70
O-Ring (for bottom glass window sealing)McMaster-Carr9452K74Dash No. 20; 7/8" ID x 1" OD; Duro 70
Plasma-Preen Plasma Cleaning/Etching SystemPlasmatic Systems, IncPlasma-PreenOxygen plasma system
RPMI 1640Life Technologies Corporation11875-093
Samco RIE800iPB DRIESamcoRIE800iPBDeep reactive-ion etching system
Suss MA6 mask alignerSUSS MicroTecMA6Mask aligner 
Sylgard 184 Silicone ElastomerFisher ScientificNC9285739PDMS elastomer
TePla M4L plasma etcherPVA TePlaM4LPlasma etcher
Trichloro-1H,1H,2H,2H-perfluorooctyl-silane (PFOTS)Sigma-Aldrich448931For silicon wafer silanization
Tygon microbore tube (0.020" x 0.060"OD)Cole-ParmerEW-06419-01Tubings for media delivery

References

  1. Meacham, C. E., Morrison, S. J. Tumour heterogeneity and cancer cell plasticity. Nature. 501 (7467), 328-337 (2013).
  2. Whiteside, T. L. The tumor microenvironment and its role in promoting tumor growth. Onc....

Explore More Articles

Microfluidic Cancer ModelEvolution AcceleratorReal time ObservationHeterogeneous Drug GradientsTumor like Stress LandscapePreclinical Drug DevelopmentPressure Sealing PackagingLong term ExperimentGas CompositionCell Line SeedingPC3 EpiPC3 EMTPDMS Devices

This article has been published

Video Coming Soon

JoVE Logo

Privacy

Terms of Use

Policies

Research

Education

ABOUT JoVE

Copyright © 2024 MyJoVE Corporation. All rights reserved